Efficacy of Daratumumab in Combination with Standard of Care Regimens in Lenalidomide-Exposed or -Refractory Patients with Relapsed/Refractory Multiple Myeloma (RRMM): Analysis of the Castor, Pollux, and MMY1001 Studies
| Autor: | Usmani, Saad Z., Mateos, Maria-Victoria, Lentzsch, Suzanne, Quach, Hang, Capra, Marcelo, Ovilla, Roberto, Jo, Jae-Cheol, Shin, Ho-Jin *, Sonneveld, Pieter, Qi, Ming, Amin, Himal *, Wang, Jianping *, Qin, Xiang *, Okonkwo, Linda *, Ukropec, Jon *, Trivedi, Sonali *, Suzuki, Kenshi, Dimopoulos, Meletios A, Cavo, Michele *, Nooka, Ajay K, Chari, Ajai, Facon, Thierry * |
|---|---|
| Zdroj: | In Blood 29 November 2018 132 Supplement 1:3288-3288 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|